Korro Bio KRRO
NASDAQ KRRO
$9.91 +0.35 (+3.66%)
At close: Sep 30, 2026 · 4:00 PM EDT

Korro Bio (KRRO) Construction in Progress (2022 - 2024)

Updated

Korro Bio (KRRO) reported Construction in Progress of $18.3 million for Q2 2024, up 36.6% from the prior quarter.

Analysis

Korro Bio (KRRO) Construction in Progress (2022 - 2024) Analysis & Trends

At the end of FY2023, Korro Bio posted Construction in Progress of $8.2 million, up 310.0% from FY2022.

  • By year, Construction in Progress came in at $2 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Korro Bio 145.73 Mn -250.91 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 18.30 Mn
Mar 31, 2024 13.40 Mn
Dec 31, 2023 8.20 Mn
Dec 31, 2022 2.00 Mn
API Access

Korro Bio Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=KRRO&period=max&api_key=YOUR_API_KEY